Daniel (Danny) Langston

Daniel Langston, who goes by Danny, is a nurse practitioner who cares for pediatric and adult patients with hereditary hemorrhagic telangiectasia (a genetic disorder that causes blood vessels to develop abnormally) at the UCSF HHT Center of Excellence and neurointerventional radiology. In addition to patient care, his duties include reviewing information on patients being referred to the clinics where he practices, including relevant imaging tests, and ordering additional imaging or other studies if needed. He also prescribes and manages medications for HHT patients, and for those receiving chemotherapy, he recommends applicable chemotherapy agents and dosing.

Langston participates in a variety of HHT research at UCSF, including a study on using an oral medication called pomalidomide to treat nosebleeds in HHT patients. His research group has published a comparison of imaging types for detecting cerebral arteriovenous malformations (abnormal connections between arteries and veins in the brain) in patients with HHT, and is studying the use of inhibitors of a protein in the body called vascular endothelial growth factor – which stimulates the development of blood vessels – for reducing nosebleeds.

Langston earned his master's degree in nursing at San Diego State University School of Nursing. In his free time, he enjoys being with friends – and nothing makes him happier than a sunset walk on the beach in Hawaii. He used to be a triathlete, but now his favorite events are breakfast, lunch and dinner.